Search Count: 43
 |
Sars-Cov-2 Mpro L50F/E166A/L167F Triple Mutant Bound To Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2025-08-20 Classification: VIRAL PROTEIN/INHIBITOR Ligands: A1BVV |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-08-20
Ligands: A1BVV
 |
Solution Structure Of The Broadspectrum Bacteriocin Garvicin Q
Organism: Lactococcus garvieae
Method: SOLUTION NMR Release Date: 2025-08-20 Classification: ANTIBIOTIC |
Organism: Lactococcus garvieae
Method: SOLUTION NMR
Release Date: 2025-08-20
 |
Soltion Structure Of His6-Small Ubiquitin-Like Modifier (His6-Sumo)
Organism: Lactococcus garvieae
Method: SOLUTION NMR Release Date: 2025-08-20 Classification: BIOSYNTHETIC PROTEIN |
Organism: Lactococcus garvieae
Method: SOLUTION NMR
Release Date: 2025-08-20
 |
Crystal Structure Of Histidine Racemase (Hisr) Of Fusobacterium Nucleatum (C67S)
Organism: Fusobacterium nucleatum
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2025-03-05 Classification: ISOMERASE Ligands: SO4 |
Organism: Fusobacterium nucleatum
Method: X-RAY DIFFRACTION
Release Date: 2025-03-05
Ligands: SO4
 |
Crystal Structure Of Histidine Racemase (Hisr) Of Fusobacterium Nucleatum (C209S)
Organism: Fusobacterium nucleatum
Method: X-RAY DIFFRACTION Resolution:2.49 Å Release Date: 2025-03-05 Classification: ISOMERASE Ligands: PO4 |
Organism: Fusobacterium nucleatum
Method: X-RAY DIFFRACTION
Release Date: 2025-03-05
Ligands: PO4
 |
Crystal Structure Of Mers-Cov Nsp5 In Complex With Pf-07817883
Organism: Middle east respiratory syndrome-related coronavirus
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2024-08-07 Classification: VIRAL PROTEIN Ligands: YDL |
Organism: Middle east respiratory syndrome-related coronavirus
Method: X-RAY DIFFRACTION
Release Date: 2024-08-07
Ligands: YDL
 |
Crystal Structure Of Main Protease Of Sars-Cov-2 Complexed With Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2024-08-07 Classification: VIRAL PROTEIN Ligands: YDL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-08-07
Ligands: YDL
 |
Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization For Enhanced Bioavailability
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2022-12-07 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: XTM |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-12-07
Ligands: XTM
 |
Structure Of Sars-Cov2 3Cl Protease Covalently Bound To Peptidomimetic Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2021-07-21 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: YWJ, FN7 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-07-21
Ligands: YWJ, FN7
 |
Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization For Enhanced Bioavailability
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2021-07-07 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: XTJ |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-07-07
Ligands: XTJ
 |
Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization For Enhanced Bioavailability
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2021-07-07 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: XTP |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-07-07
Ligands: XTP
 |
Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization For Enhanced Bioavailability
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2021-07-07 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: XU4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-07-07
Ligands: XU4
 |
Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization For Enhanced Bioavailability
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2021-07-07 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: XV4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-07-07
Ligands: XV4
 |
N-Terminal Finger Stabilizes Feline Drug Gc376 In Coronavirus 3Cl Protease
Organism: Severe acute respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2021-05-12 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: UED, EDO, CA |
Organism: Severe acute respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION
Release Date: 2021-05-12
Ligands: UED, EDO, CA
 |
N-Terminal Finger Stabilizes Feline Drug Gc376 In Coronavirus 3Cl Protease
Organism: Severe acute respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2021-05-12 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: EDO, UED |
Organism: Severe acute respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION
Release Date: 2021-05-12
Ligands: EDO, UED
 |
Feline Coronavirus Drug Inhibits The Main Protease Of Sars-Cov-2 And Blocks Virus Replication
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2020-05-20 Classification: Hydrolase/Hydrolase Inhibitor Ligands: K36 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2020-05-20
Ligands: K36
 |
Feline Coronavirus Drug Inhibits The Main Protease Of Sars-Cov-2 And Blocks Virus Replication
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2020-05-20 Classification: Hydrolase/Hydrolase Inhibitor Ligands: UED |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2020-05-20
Ligands: UED
 |
Feline Coronavirus Drug Inhibits The Main Protease Of Sars-Cov-2 And Blocks Virus Replication
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2020-05-20 Classification: Hydrolase/Hydrolase Inhibitor |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2020-05-20
 |
Phenol-Soluble Modulin Alpha 3
Organism: Staphylococcus aureus (strain bovine rf122 / et3-1)
Method: SOLUTION NMR Release Date: 2016-08-31 Classification: STRUCTURE FROM CYANA 2.1 |
Organism: Staphylococcus aureus (strain bovine rf122 / et3-1)
Method: SOLUTION NMR
Release Date: 2016-08-31
 |
Phenol-Soluble Modulin Beta2
Organism: Staphylococcus aureus
Method: SOLUTION NMR Release Date: 2016-08-31 Classification: Virulence Factor |
Organism: Staphylococcus aureus
Method: SOLUTION NMR
Release Date: 2016-08-31